CD8A and colorectal carcinoma: The same phenomenon was also observed in anti-CD8 and anti-CD4 neutralizing antibody therapy trials (Figure 1J and Figure S2C), indicating 5Aza inhibition of CRC-PC progression via lymphocytes.